Biofrontera Inc.
Biofrontera Inc. (BFRI): 4 pipeline candidates · 1 upcoming catalyst · ~365 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
364.7 months
D/E 3.08 · 0% dilution
Lead: Approved
4 candidates
1 upcoming, next in ~6382d
N/A
A transparent, data-derived signal for Biofrontera Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$12.8M
Cash
$6.5M
Quarterly Burn
$70K
Runway
364.7 mo
Revenue
$10.1M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
| Drug | Phase |
|---|---|
| ameluz | Phase 3 |
| Ameluz® | Phase 3 |
| RhodoLED® Lamps (including RhodoLED® XL) | Approved |
| Xepi® | Approved |
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
9
Total value held
$287K
| Holder | Shares | Value |
|---|---|---|
| geode capital management, llc | 109,300 | $88K |
| vanguard capital management llc | 104,508 | $85K |
| vanguard fiduciary trust co | 61,697 | $50K |
| susquehanna international group, llp | 38,574 | $31K |
| xtx topco ltd | 22,493 | $18K |
| citigroup inc | 11,837 | $10K |
| blackrock, inc. | 4,622 | $4K |
| ubs group ag | 1,540 | $1K |
| sbi securities co., ltd. | 305 | $247 |
Frequently asked questions
How many drug candidates are in Biofrontera Inc.'s pipeline?
Biofrontera Inc. (BFRI) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Biofrontera Inc.'s lead drug candidate?
Biofrontera Inc.'s most advanced tracked candidate is ameluz (Phase 3) for Actinic Keratosis (Trunk & extremities).
What is Biofrontera Inc.'s next catalyst?
Biofrontera Inc.'s next tracked catalyst is a Patent_Expiry event — "Patent/Exclusivity Expiry: AMELUZ" — expected December 8, 2043.
What is Biofrontera Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Biofrontera Inc. has approximately 364.7 months of cash runway.
What is Biofrontera Inc.'s market capitalization?
Biofrontera Inc.'s market capitalization is approximately $12.8M.
Get the full picture on Biofrontera Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.